These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P, Haddadi A. Int J Nanomedicine; 2017 Jan; 12():935-947. PubMed ID: 28184163 [Abstract] [Full Text] [Related]
3. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS, Mei L, Anitha P, Gan CW, Zhou W. Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [Abstract] [Full Text] [Related]
8. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability. Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE. Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220 [Abstract] [Full Text] [Related]
9. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. Lee SW, Yun MH, Jeong SW, In CH, Kim JY, Seo MH, Pai CM, Kim SO. J Control Release; 2011 Oct 30; 155(2):262-71. PubMed ID: 21704664 [Abstract] [Full Text] [Related]
14. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Wang L, Liu Z, Liu D, Liu C, Juan Z, Zhang N. Int J Pharm; 2011 Jul 15; 413(1-2):194-201. PubMed ID: 21540085 [Abstract] [Full Text] [Related]
15. Characterization and in-vitro bioactivity evaluation of paclitaxel-loaded polyester nanoparticles. López-Gasco P, Iglesias I, Benedí J, Lozano R, Blanco MD. Anticancer Drugs; 2012 Oct 15; 23(9):947-58. PubMed ID: 22713593 [Abstract] [Full Text] [Related]
16. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo. Alibolandi M, Abnous K, Hadizadeh F, Taghdisi SM, Alabdollah F, Mohammadi M, Nassirli H, Ramezani M. J Control Release; 2016 Nov 10; 241():45-56. PubMed ID: 27639681 [Abstract] [Full Text] [Related]
17. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. Hwang HY, Kim IS, Kwon IC, Kim YH. J Control Release; 2008 May 22; 128(1):23-31. PubMed ID: 18374444 [Abstract] [Full Text] [Related]
18. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Liu Q, Li R, Zhu Z, Qian X, Guan W, Yu L, Yang M, Jiang X, Liu B. Int J Pharm; 2012 Jul 01; 430(1-2):350-8. PubMed ID: 22525076 [Abstract] [Full Text] [Related]
19. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer. Ghassami E, Varshosaz J, Jahanian-Najafabadi A, Minaiyan M, Rajabi P, Hayati E. Int J Nanomedicine; 2018 Jul 01; 13():493-504. PubMed ID: 29416331 [Abstract] [Full Text] [Related]
20. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R, Ramasamy T, Choi JY, Kim JH, Poudel BK, Tak JW, Nukolova N, Choi HG, Yong CS, Kim JO. Carbohydr Polym; 2015 Jun 05; 123():313-23. PubMed ID: 25843864 [Abstract] [Full Text] [Related] Page: [Next] [New Search]